493
Participants
Start Date
November 11, 2019
Primary Completion Date
April 23, 2021
Study Completion Date
September 9, 2022
DTG/3TC FDC
DTG/3TC FDC will be available as white, oval, film-coated tablets at a unit dose strength of 50 mg/300 mg. Participants will take DTG/3TC once daily via oral route.
CAR
Participants who are randomized to the CAR arm will continue to take the current treatment until Week 52. CAR will include 2 NTRIs plus either an INI, NNRTI, or boosted PI or atazanavir unboosted.
GSK Investigational Site, New Taipei City
GSK Investigational Site, Taoyuan District
GSK Investigational Site, Taichung
GSK Investigational Site, Kaohsiung City
GSK Investigational Site, Brussels
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Antwerp
GSK Investigational Site, Hvidovre
GSK Investigational Site, Odense C
GSK Investigational Site, Nice
GSK Investigational Site, Cape Town
GSK Investigational Site, Observatory, Cape Town
GSK Investigational Site, Aarhus
GSK Investigational Site, Badalona, Barcelona
GSK Investigational Site, Ghent
GSK Investigational Site, Bloemfontein
GSK Investigational Site, Taipei
GSK Investigational Site, Cadiz
GSK Investigational Site, A Coruña
GSK Investigational Site, Granada
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Milan
GSK Investigational Site, Milan
GSK Investigational Site, Hamburg
GSK Investigational Site, Milan
GSK Investigational Site, Hamburg
GSK Investigational Site, Bergamo
GSK Investigational Site, Brescia
GSK Investigational Site, Morgantown
GSK Investigational Site, Pavia
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, San Sebastián de los Reyes
GSK Investigational Site, Murcia
GSK Investigational Site, Atlanta
GSK Investigational Site, Toulouse
GSK Investigational Site, Savannah
GSK Investigational Site, Pensacola
GSK Investigational Site, Bordeaux
GSK Investigational Site, West Palm Beach
GSK Investigational Site, Santa Cruz de Tenerife
GSK Investigational Site, Seville
GSK Investigational Site, Modena
GSK Investigational Site, Guadalajara
GSK Investigational Site, Guadalajara
GSK Investigational Site, Orléans
GSK Investigational Site, Essen
GSK Investigational Site, Zapopan
GSK Investigational Site, Valencia
GSK Investigational Site, Cologne
GSK Investigational Site, Cologne
GSK Investigational Site, Bonn
GSK Investigational Site, Milwaukee
GSK Investigational Site, Tourcoing
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, St Louis
GSK Investigational Site, Kansas City
GSK Investigational Site, Tulsa
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Munich
GSK Investigational Site, München
GSK Investigational Site, Kaohsiumg
GSK Investigational Site, München
GSK Investigational Site, Los Angeles
GSK Investigational Site, Newport Beach
GSK Investigational Site, Bobigny
GSK Investigational Site, San Francisco
GSK Investigational Site, Beijing
GSK Investigational Site, Beijing
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Shanghai
GSK Investigational Site, Chongqing
GSK Investigational Site, Tolyatti
GSK Investigational Site, Guangzhou
GSK Investigational Site, Yekaterinburg
GSK Investigational Site, New Haven
GSK Investigational Site, Hillsborough
GSK Investigational Site, Ciudad Autonoma de Buenos Aires
GSK Investigational Site, Ciudad de Buenos Aires
GSK Investigational Site, Rosario
GSK Investigational Site, Salvador
GSK Investigational Site, Curitiba
GSK Investigational Site, Campinas
GSK Investigational Site, Manaus
GSK Investigational Site, Rio de Janeiro
GSK Investigational Site, São Paulo
GSK Investigational Site, São Paulo
GSK Investigational Site, Vancouver
GSK Investigational Site, Winnipeg
GSK Investigational Site, Ottawa
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Montreal
GSK Investigational Site, Regina
GSK Investigational Site, Copenhagen
GSK Investigational Site, Rome
GSK Investigational Site, Rome
GSK Investigational Site, Distrito Federal
GSK Investigational Site, Palma de Mallorca
GSK Investigational Site, Gothenburg
GSK Investigational Site, Malmo
GSK Investigational Site, Stockholm
GSK Investigational Site, Stockholm
GSK Investigational Site, Leeds
GSK Investigational Site, Birmingham
GSK Investigational Site, Brighton
GSK Investigational Site, Bristol
GSK Investigational Site, Liverpool
GSK Investigational Site, London
GSK Investigational Site, London
GSK Investigational Site, Manchester
GSK Investigational Site, Manchester
GSK Investigational Site, Newcastle upon Tyne
GSK Investigational Site, Sheffield
Lead Sponsor
Collaborators (2)
GlaxoSmithKline
INDUSTRY
PPD Development, LP
INDUSTRY
ViiV Healthcare
INDUSTRY